136 related articles for article (PubMed ID: 37979055)
21. Peripheral neuroblastic tumors: pathologic classification based on recommendations of international neuroblastoma pathology committee (Modification of shimada classification).
Joshi VV
Pediatr Dev Pathol; 2000; 3(2):184-99. PubMed ID: 10679039
[No Abstract] [Full Text] [Related]
22. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
23. Peripheral neuroblastic tumours in eastern Denmark 1972-2002.
Zimling ZG; Rechnitzer C; Rasmussen M; Petersen BL
APMIS; 2007 Jan; 115(1):66-74. PubMed ID: 17223852
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of neuroblastoma: analysis of a single institution.
Izbicki T; Mazur J; Izbicka E
Anticancer Res; 2003; 23(2C):1933-8. PubMed ID: 12820482
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of radiomic features from computed tomography for preoperative classification of neuroblastic tumors in children.
Zhao L; Shi L; Huang SG; Cai TN; Guo WL; Gao X; Wang J
BMC Pediatr; 2023 May; 23(1):262. PubMed ID: 37226234
[TBL] [Abstract][Full Text] [Related]
26. Peripheral neuroblastic tumors and congenital heart disease. Possible role of hypoxic states in tumor induction.
de la Monte SM; Hutchins GM; Moore GW
Am J Pediatr Hematol Oncol; 1985; 7(2):109-16. PubMed ID: 3842556
[TBL] [Abstract][Full Text] [Related]
27. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
Munchar MJ; Sharifah NA; Jamal R; Looi LM
Pathology; 2003 Apr; 35(2):125-9. PubMed ID: 12745459
[TBL] [Abstract][Full Text] [Related]
28. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.
Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S
Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823
[TBL] [Abstract][Full Text] [Related]
29. Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.
Banelli B; Bonassi S; Casciano I; Mazzocco K; Di Vinci A; Scaruffi P; Brigati C; Allemanni G; Borzì L; Tonini GP; Romani M
Int J Cancer; 2010 Feb; 126(3):656-68. PubMed ID: 19626586
[TBL] [Abstract][Full Text] [Related]
30. Management of Primary Thoracic Neuroblastic Tumors in Children: An Observational Study.
Shanmugam V; Vinayagam NK; Senthilnathan R
J Indian Assoc Pediatr Surg; 2022; 27(2):131-135. PubMed ID: 35937126
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of histopathologic types of childhood peripheral neuroblastic tumors based on clinical and biological factors.
Yang S; Cai S; Ma X; Zeng Q; Qin H; Han W; Peng X; Wang H
Sci Rep; 2018 Jul; 8(1):10924. PubMed ID: 30026516
[TBL] [Abstract][Full Text] [Related]
32. Urinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children's neuroblastic tumors.
Izbicki T; Bozek J; Perek D; Wozniak W
J Pediatr Surg; 1991 Oct; 26(10):1230-4. PubMed ID: 1779334
[TBL] [Abstract][Full Text] [Related]
33. Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group.
Joshi VV; Cantor AB; Altshuler G; Larkin EW; Neill JS; Shuster JJ; Holbrook CT; Hayes FA; Castleberry RP
Cancer; 1992 Apr; 69(8):2183-96. PubMed ID: 1544124
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data.
Tabyaoui I; Tahiri-Jouti N; Serhier Z; Bennani-Othmani M; Sibai H; Itri M; Benchekroun S; Zamiati S
Diagn Pathol; 2013 Feb; 8():39. PubMed ID: 23445749
[TBL] [Abstract][Full Text] [Related]
35. Temporal clustering of neuroblastic tumours in children and young adults from Northern England.
Muirhead CR; Tweddle DA; Basta NO; McNally RJ
Environ Health; 2015 Sep; 14():72. PubMed ID: 26338008
[TBL] [Abstract][Full Text] [Related]
36. Whole-tumor radiomics analysis of T2-weighted imaging in differentiating neuroblastoma from ganglioneuroblastoma/ganglioneuroma in children: an exploratory study.
Wang H; Chen X; Yu W; Xie M; Zhang L; Ding H; Li T; Qin J; He L
Abdom Radiol (NY); 2023 Apr; 48(4):1372-1382. PubMed ID: 36892608
[TBL] [Abstract][Full Text] [Related]
37. Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
Heide S; Masliah-Planchon J; Isidor B; Guimier A; Bodet D; Coze C; Deville A; Thebault E; Pasquier CJ; Cassagnau E; Pierron G; Clément N; Schleiermacher G; Amiel J; Delattre O; Peuchmaur M; Bourdeaut F
Pediatr Blood Cancer; 2016 Jan; 63(1):71-7. PubMed ID: 26375764
[TBL] [Abstract][Full Text] [Related]
38. Comparison of ultrastructural features among neuroblastic tumors: maturation from neuroblastoma to ganglioneuroma.
Hicks MJ; Mackay B
Ultrastruct Pathol; 1995; 19(4):311-22. PubMed ID: 7571090
[TBL] [Abstract][Full Text] [Related]
39. PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors.
Bielle F; Fréneaux P; Jeanne-Pasquier C; Maran-Gonzalez A; Rousseau A; Lamant L; Paris R; Pierron G; Nicolas AV; Sastre-Garau X; Delattre O; Bourdeaut F; Peuchmaur M
Am J Surg Pathol; 2012 Aug; 36(8):1141-9. PubMed ID: 22790854
[TBL] [Abstract][Full Text] [Related]
40. Stage-specific expression of integrin alphaVbeta3 in neuroblastic tumors.
Gladson CL; Hancock S; Arnold MM; Faye-Petersen OM; Castleberry RP; Kelly DR
Am J Pathol; 1996 May; 148(5):1423-34. PubMed ID: 8623914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
